高级检索
    林宁晶, 朱军. 2019年度恶性淋巴瘤主要进展——遵循循证医学证据,持续推进淋巴瘤规范化诊疗[J]. 循证医学, 2020, 20(2): 65-71. DOI: 10.12019/j.issn.1671-5144.2020.02.001
    引用本文: 林宁晶, 朱军. 2019年度恶性淋巴瘤主要进展——遵循循证医学证据,持续推进淋巴瘤规范化诊疗[J]. 循证医学, 2020, 20(2): 65-71. DOI: 10.12019/j.issn.1671-5144.2020.02.001
    shu
    LIN Ning-jing, ZHU Jun. Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 65-71. DOI: 10.12019/j.issn.1671-5144.2020.02.001
    Citation: LIN Ning-jing, ZHU Jun. Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma[J]. Journal of Evidence-Based Medicine, 2020, 20(2): 65-71. DOI: 10.12019/j.issn.1671-5144.2020.02.001
    shu

    2019年度恶性淋巴瘤主要进展——遵循循证医学证据,持续推进淋巴瘤规范化诊疗

    Major Progress of Malignant Lymphoma in 2019-Follow Evidence-based Medicine, and Continue to Promote the Standardization of Diagnosis and Treatment of Lymphoma

      摘要
      • HTML全文
      • 参考文献(58)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回